Medicare Enrolled
Dr. Roshni Karnani, M.D.
Neurology · Rye Brook, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Karnani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Karnani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Karnani
Dr. Roshni Karnani is a neurology specialist in Rye Brook, NY, with 17 years of NPI registration. Based on federal Medicare data, Dr. Karnani performed 1,452 Medicare services across 780 unique beneficiaries.
Between the years covered by Open Payments, Dr. Karnani received a total of $9,792 from 53 pharmaceutical and/or device companies across 354 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Karnani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 22% volume in NY
$9,792 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,452
Medicare services
Top 22% in NY for neurology
780
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~85 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
358 | $102 | $200 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
239 | $4 | $50 |
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
221 | $5 | $14 |
| Magnetic field treatment to stimulate brain nerve cells A procedure using a magnetic field to stimulate nerve cells in the brain, including the delivery and management of the treatment. |
209 | $172 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
130 | $138 | $300 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
93 | $77 | $175 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
92 | $91 | $400 |
| Video EEG monitoring, 12-26 hours Continuous monitoring of brain wave activity combined with video recording for 12 to 26 hours. |
29 | $983 | $3,862 |
| New patient office visit, complex (60-74 min) | 28 | $190 | $350 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
16 | $196 | $1,200 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
15 | $264 | $1,400 |
| 30-day continuous ECG with symptom monitoring This procedure involves continuous electrocardiogram monitoring for up to 30 days, including symptom tracking and a professional review and report of the results. |
11 | $161 | $236 |
| Continuous EEG brain wave monitoring A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously. |
11 | $157 | $3,145 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,792
Total received (2018-2024)
Avg $1,399/year across 7 years
Top 25% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
354
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,629 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$163 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,338
2023
$1,951
2022
$1,425
2021
$1,125
2020
$685
2019
$1,181
2018
$1,088
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$313
Lundbeck LLC
$299
Amneal Pharmaceuticals LLC
$243
PFIZER INC.
$226
Lilly USA, LLC
$203
Alexion Pharmaceuticals, Inc.
$193
Otsuka America Pharmaceutical, Inc.
$191
Eisai Inc.
$157
Kyowa Kirin, Inc.
$108
TG Therapeutics, Inc.
$68
SK Life Science, Inc.
$60
Novartis Pharmaceuticals Corporation
$52
UCB, Inc.
$46
Sumitomo Pharma America, Inc.
$40
Neuronetics, Inc.
$30
IDORSIA PHARMACEUTICALS US INC
$25
Azurity Pharmaceuticals, Inc.
$25
Medtronic, Inc.
$23
Collegium Pharmaceutical, Inc.
$23
SCILEX PHARMACEUTICALS INC.
$15
Top 3 companies account for 36.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$889
Amneal Pharmaceuticals LLC
$695
Alexion Pharmaceuticals, Inc.
$677
Biogen, Inc.
$633
Otsuka America Pharmaceutical, Inc.
$607
Teva Pharmaceuticals USA, Inc.
$502
PFIZER INC.
$466
Kyowa Kirin, Inc.
$434
Lilly USA, LLC
$363
Lundbeck LLC
$321
AbbVie Inc.
$300
Amgen Inc.
$270
Novartis Pharmaceuticals Corporation
$265
Medtronic Vascular, Inc.
$260
SK Life Science, Inc.
$237
Genentech USA, Inc.
$226
Biohaven Pharmaceutical Holding Company Ltd.
$219
IDORSIA PHARMACEUTICALS US INC
$217
EMD Serono, Inc.
$211
Eisai Inc.
$196
GENZYME CORPORATION
$141
Sumitomo Pharma America, Inc.
$129
Neuronetics, Inc.
$128
Adamas Pharmaceuticals, Inc.
$125
UCB, Inc.
$119
Allergan, Inc.
$117
Almatica Pharma LLC
$97
Harmony Biosciences LLC
$87
ARBOR PHARMACEUTICALS, INC.
$73
TG Therapeutics, Inc.
$68
IMPEL PHARMACEUTICALS INC.
$66
Avanir Pharmaceuticals, Inc.
$63
ACADIA Pharmaceuticals Inc
$61
Upsher-Smith Laboratories LLC
$60
Scilex Pharmaceuticals Inc.
$47
Sunovion Pharmaceuticals Inc.
$45
ARGENX US, INC.
$44
Supernus Pharmaceuticals, Inc.
$34
UPSHER-SMITH LABORATORIES LLC
$29
Currax Pharmaceuticals LLC
$27
Azurity Pharmaceuticals, Inc.
$25
Biohaven Pharmaceuticals, Inc.
$24
TG THERAPEUTICS, INC.
$24
Medtronic, Inc.
$23
Collegium Pharmaceutical, Inc.
$23
Avion Pharmaceuticals
$22
CATALYST PHARMACEUTICALS, INC.
$21
SCILEX PHARMACEUTICALS INC.
$15
ASSERTIO THERAPEUTICS, Inc.
$14
Medtronic USA, Inc.
$13
Alfasigma USA, Inc.
$13
Egalet US Inc
$13
Neurocrine Biosciences, Inc.
$12
Top 3 companies account for 23.1% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BOTOX · BRIUMVI · Belbuca · Briviact · COMIRNATY · CONTRAVE · CREXONT · DUOPA · Dhivy · Evekeo · FIRDAPSE · GILENYA · GOCOVRI · GRALISE · HORIZANT · Horizant · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LYVISPAH · Leqembi · MAYZENT · Mavenclad · NAPRELAN · NEUROSTAR TMS THERAPY SYSTEM · NOURIANZ · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · ONGENTYS · PERCEPT PC BRAINSENSE · QULIPTA · QUVIVIQ · REXULTI · RYTARY · Reveal LINQ · Rystiggo · SOLIRIS · SPRIX · Soliris · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · Trudhesa · UBRELVY · ULTOMIRIS · VRAYLAR · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · ZEMBRACE SYMTOUCH · ZTLido · Zilbrysq · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
1,000
Per 100K population
100.3
County median income
$118,411
Nearest hospital
GREENWICH HOSPITAL ASSOCIATION -
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Karnani is a clinical cardiology specialist, with above-average Medicare volume (top 22% in NY), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Karnani experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Karnani performed 358 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Karnani receive payments from pharmaceutical companies?
Yes. Dr. Karnani received a total of $9,792 from 53 companies across 354 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Karnani's costs compare to other neurologists in Rye Brook?
Dr. Karnani's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Karnani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Rye Brook
Browse neurologists in Rye Brook ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Amneal Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Amneal Pharmaceuticals LLC.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology